Texas A&M University

Texas A&M researchers design 3D-printed diffuser to treat COVID-19 patients

8-Apr-2020 6:05 PM EDT, by Texas A&M University

Newswise — Texas A&M University, through its unique Engineering Medicine (EnMed) partnership with Houston Methodist Hospital, is stepping up to help the health care system keep up with the demand for medical supplies brought on by the increasing number of confirmed and suspected COVID-19 cases.

A team led by Dr. Michael R. Moreno has already delivered 200 3D-printed diffusers for metered dose inhalers (MDI) to the Houston hospital and stands ready to produce more if needed.

“The spacer, or diffuser, that we created will allow the doctors to use metered dose inhalers to treat diagnosed and suspected COVID-19 patients who are not yet in need of ventilator therapy, without using nebulizers that may aerosolize the virus,” Moreno said. “And this is important because if this early stage intervention is effective, then it is possible that these patients may recover before reaching that critical point where ventilator therapy is required.”

Moreno, assistant professor in the J. Mike Walker ‘66 Department of Mechanical Engineering and director of innovation for Engineering Medicine, said the hospital was facing a critical shortage after being unable to find the diffusers from its normal suppliers.

He said one of the most powerful aspects of the project is that it came from direct communication with doctors who, at the forefront of this crisis, are identifying emerging unanticipated needs.

“In some cases, the solutions are not that complicated, but you have to know that the problems exist,” Moreno said. “And the only way you’re going to know that as an engineer is if you have an open line of communication with the doctors.”

While ventilators are reserved for patients experiencing severe symptoms, respiratory inhalers are a part of the early treatment plan for most hospitalized patients exhibiting signs of COVID-19 infection.

Bronchodilator drugs used for treatment of asthma can be utilized in COVID-19 patients to improve their ability to breathe. In the hospital setting, these would typically be administered using nebulizers. The concern is that the use of nebulizers could aerosolize the virus, placing those in the area at higher risk of contracting the disease.

Consequently, inhalers are the preferred method of delivery for these drugs with confirmed and potential COVID-19 patients. The inhaler devices require precise timing of inhalation for proper delivery to the lungs, which is something Moreno said even experienced users, like himself, can find challenging.

With the help of a diffuser, patients are better able to get more of the medication into their lungs.

“These spacers work like diffusers and allow the patient more time to draw the entire dose of medication into their lungs” Moreno said. “And when you're suffering from respiratory illness, this may be very important.”

While ventilators are reserved for patients experiencing severe symptoms, respiratory inhalers are a part of the early treatment plan for most hospitalized patients exhibiting signs of COVID-19 infection.

Bronchodilator drugs used for treatment of asthma can be utilized in COVID-19 patients to improve their ability to breathe. In the hospital setting, these would typically be administered using nebulizers. The concern is that the use of nebulizers could aerosolize the virus, placing those in the area at higher risk of contracting the disease.

Consequently, inhalers are the preferred method of delivery for these drugs with confirmed and potential COVID-19 patients. The inhaler devices require precise timing of inhalation for proper delivery to the lungs, which is something Moreno said even experienced users, like himself, can find challenging.

With the help of a diffuser, patients are better able to get more of the medication into their lungs.

“These spacers work like diffusers and allow the patient more time to draw the entire dose of medication into their lungs” Moreno said. “And when you're suffering from respiratory illness, this may be very important.”

Dan Metzen, system director of pharmacy services at Houston Methodist, said diffusers – such as the commercially available Aerochamber - are currently in short supply due to the increased use of inhalers for both confirmed and suspected COVID-19 patients, leaving the hospital itself with a limited supply.

Although Metzen said nebulizers could also be used to administer the medication, metered dose inhalers are preferred due to a concern that nebulizers used by patients with COVID-19 in the hospital could spread the virus.

Houston Methodist has a partnership with the Texas A&M College of Medicine and College of Engineering through the EnMed program, an integrated educational and research medical program with a focus on innovation. Dr. Roderic Pettigrew, executive dean of EnMed, said this rapid response by Moreno and his team to develop a use-inspired solution in the 3D printed diffuser serves as a perfect example of the program’s concept in action.

“Engineers are great at solving problems that benefit society and the health care delivery system, right now, is very much in need of help with problem solving as we struggle with this pandemic and all of its associated challenges,” Pettigrew said. “EnMed has risen to the occasion right here in Houston to serve people in need. We’re working with our colleagues at Houston Methodist Hospital in order to devise practical solutions to real problems on the front lines of treating COVID-19 patients.”

Although the concept being utilized for the diffusers is not new, this is among the first times it has been locally 3D printed and delivered on this scale.

Anticipating that this shortage is likely not unique to Houston Methodist, Moreno and his team are making the stereolithography (STL) file for the 3D-printable design publicly available, at no cost, on the EnMed website.

“People will be able to go to the site, download those STL files and then print these spacers for their local hospitals as well, if they find that they have need for it,” Moreno said.

Additionally, the team has designed an alternate, smaller 3D-printable device designed for areas that may be more resource limited. This device is essentially an inhaler interface that allows one to use a common plastic water bottle as the diffuser chamber.

Moreno said his team, as well as several others throughout The Texas A&M University System, have worked tirelessly to make sure they would be able to deliver the diffusers to patients in need as soon as possible.

“As an Aggie biomedical engineer and mechanical engineer working in this biomedical space, times like these are when we really want to rise to the challenge,” Moreno said. “Right now, there are patients that are using these spacers, or diffusers, and we’re very hopeful about addressing future problems as well. This is just what we do as Aggie engineers.”




Filters close

Showing results

110 of 2927
Released: 14-Aug-2020 4:55 PM EDT
Managing your child’s diabetes during COVID-19
University of Texas Health Science Center at Houston

These days it’s hard not to worry about whether a quick outing to the grocery store will result in catching COVID-19. But for parents with children who have preexisting health conditions such as diabetes, it can be especially hard not to worry about whether their child is at a higher risk of becoming severely ill from the virus.

Newswise: 1200x800?cb=1597350935
Released: 14-Aug-2020 3:35 PM EDT
Gaiters do no harm: WVU toxicologists find coverings help contain the spread of exhaled droplets
West Virginia University

Experts with the West Virginia University Center for Inhalation Toxicology found that – assuming it’s a good fit - a gaiter will, despite recent reports, provide a respiratory containment of exhaled droplets comparable to a common over-the-ear cloth mask.

Newswise: AI software enables real-time 3D printing quality assessment
Released: 14-Aug-2020 3:05 PM EDT
AI software enables real-time 3D printing quality assessment
Oak Ridge National Laboratory

Oak Ridge National Laboratory researchers have developed artificial intelligence software for powder bed 3D printers that assesses the quality of parts in real time, without the need for expensive characterization equipment.

Newswise: Is the COVID-19 virus pathogenic because it depletes specific host microRNAs?
Released: 14-Aug-2020 3:05 PM EDT
Is the COVID-19 virus pathogenic because it depletes specific host microRNAs?
University of Alabama at Birmingham

Why is the COVID-19 virus deadly, compared to cold-causing coronaviruses? Analysis current literature and bioinformatic study of seven coronaviruses, suggests that SARS-CoV-2 acts as a microRNA “sponge,” leading to better viral replication and blockage of the host immune response.

Released: 14-Aug-2020 2:30 PM EDT
UW team developing model to help lower COVID-19 infections in Seattle, other major cities
University of Washington

A UW team has received a grant to develop a model that uses local data to generate policy recommendations that could help lower COVID-19 infections in King County, which includes Seattle.

Newswise: Cardiovascular risk factors tied to COVID-19 complications and death
12-Aug-2020 7:05 PM EDT
Cardiovascular risk factors tied to COVID-19 complications and death
PLOS

COVID-19 patients with cardiovascular comorbidities or risk factors are more likely to develop cardiovascular complications while hospitalized, and more likely to die from COVID-19 infection, according to a new study published August 14, 2020 in the open-access journal PLOS ONE by Jolanda Sabatino of Universita degli Studi Magna Graecia di Catanzaro, Italy, and colleagues.

Newswise: Study shows frequently used serology test may not detect antibodies that could confirm protection against reinfection of COVID-19
Released: 14-Aug-2020 1:55 PM EDT
Study shows frequently used serology test may not detect antibodies that could confirm protection against reinfection of COVID-19
University of Texas M. D. Anderson Cancer Center

Two different types of detectable antibody responses in SARS-CoV-2 (COVID-19) tell very different stories and may indicate ways to enhance public health efforts against the disease, according to researchers at The University of Texas MD Anderson Cancer Center. Antibodies to the SARS-CoV-2 spike protein receptor binding domain (S-RBD) are speculated to neutralize virus infection, while the SARS-CoV-2 nucleocapsid protein (N-protein) antibody may often only indicate exposure to the virus, not protections against reinfection.

Released: 14-Aug-2020 1:50 PM EDT
USC scientists identify the order of COVID-19's symptoms
University of Southern California (USC)

USC researchers have found the likely order in which COVID-19 symptoms first appear: fever, cough, muscle pain, and then nausea, and/or vomiting, and diarrhea.

Released: 14-Aug-2020 1:45 PM EDT
Stay the Course with Personal Finances during Pandemic, Johns Hopkins Expert Advises
Johns Hopkins University Carey Business School

Keeping on a careful and steady path is the wisest approach to personal money management during the uncertainties of the COVID-19 crisis, says Associate Professor Yuval Bar-Or of the Johns Hopkins Carey Business School.

access_time Embargo lifts in 2 days
Embargo will expire: 17-Aug-2020 11:00 AM EDT Released to reporters: 14-Aug-2020 1:25 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 17-Aug-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Showing results

110 of 2927

close
0.78807